^
BIOMARKER:

KRAS G13

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
KRAS G13
CRC
cetuximab
Resistant: A1 - Approval
KRAS G13
CRC
panitumumab
Resistant: A1 - Approval
KRAS G13
CRC
bevacizumab
Sensitive: C3 – Early Trials
KRAS G13
CRC
cobimetinib + HM95573
Sensitive: C3 – Early Trials
KRAS G13
CRC
AZD1775
Sensitive: C3 – Early Trials
KRAS G13
CRC
selumetinib + RTB101
Sensitive: D – Preclinical
KRAS G13
CRC
RTB101
Sensitive: D – Preclinical
KRAS G13
CRC
selumetinib
Sensitive: D – Preclinical